People: IsoRay Inc (ISR)
ISR on American Stock Exchange
0.49USD
23 May 2013
0.49USD
23 May 2013
Price Change (% chg)
$-0.02 (-3.92%)
$-0.02 (-3.92%)
Prev Close
$0.51
$0.51
Open
$0.48
$0.48
Day's High
$0.50
$0.50
Day's Low
$0.48
$0.48
Volume
15,100
15,100
Avg. Vol
132,755
132,755
52-wk High
$1.60
$1.60
52-wk Low
$0.35
$0.35
Summary
| Name | Age | Since | Current Position |
|---|---|---|---|
Dwight Babcock |
65 | 2012 | Chairman of the Board, Chief Executive Officer |
Robert Kauffman |
72 | 2008 | Independent Vice Chairman of the Board |
Brien Ragle |
43 | 2009 | Principal Financial and Accounting Officer, Controller |
Fred Swindler |
65 | Vice President - Regulatory and Quality Assurance | |
William Cavanagh |
47 | 2010 | Vice President - Research and Development |
Thomas LaVoy |
53 | 2005 | Independent Director |
Albert Smith |
69 | 2006 | Independent Director |
Biographies
| Name | Description |
|---|---|
Dwight Babcock |
Mr. Dwight Babcock is Chairman of the Board, Chief Executive Officer of IsoRay Inc. Mr. Babcock was appointed CEO of the Company on February 18, 2009. He was previously appointed Chairman and Interim CEO of the Company on February 26, 2008 and has served as a Director of the Company since 2006. Mr. Babcock has served as Chairman and Chief Executive Officer of Apex Data Systems, Inc., an information technology company, since 1975. Apex Data Systems automates the administration and claims adjudication needs of insurance companies both nationally and internationally. Mr. Babcock was formerly President and CEO of Babcock Insurance Corporation (BIC) from 1974 until 1985. BIC was a nationally recognized third party administrator operating within 35 states. Mr. Babcock has knowledge and experience in the equity arena and has participated in various activities within the venture capital, private and institutional capital markets. Mr. Babcock studied marketing and economics at the University of Arizona where he currently serves on the University of Arizona Astronomy Board. Mr. Babcock brings over 35 years of CEO-level experience to his service on the Company's Board. |
Robert Kauffman |
Mr. Robert Kauffman is Independent Vice Chairman of the Board of IsoRay Inc. Mr. Kauffman has been a Director of the Company since 2005 and was appointed Vice-Chairman of the Company on February 26, 2008. Mr. Kauffman has served as Chief Executive Officer and Chairman of the Board of Alanco Technologies, Inc. (OTCBB: ALAN), an Arizona-based information technology company, since July 1, 1998. Mr. Kauffman was formerly President and Chief Executive Officer of NASDAQ-listed Photocomm, Inc., from 1988 until 1997 (since renamed Kyocera Solar, Inc.). Photocomm was the publicly owned manufacturer and marketer of wireless solar electric power systems with annual revenues in excess of $35 million. Prior to Photocomm, Mr. Kauffman was a senior executive of the Atlantic Richfield Company (ARCO) whose varied responsibilities included Senior Vice President of ARCO Solar, Inc., President of ARCO Plastics Company and Vice President of ARCO Chemical Company. Mr. Kauffman earned an M.B.A. in Finance at the Wharton School of the University of Pennsylvania, and holds a B.S. in Chemical Engineering from Lafayette College, Easton, Pennsylvania. Mr. Kauffman has substantial experience in serving as CEO for public companies, and brings these skills to his service on the Company's Board. |
Brien Ragle |
Mr. Brien Ragle is Principal Financial and Accounting Officer, Controller of IsoRay Inc. Mr. Ragle has over 15 years of finance and accounting experience, including SEC reporting, financial reporting, cost, project, and management accounting in addition to performing operational analysis. Mr. Ragle became IsoRay's Controller – Principal Financial and Accounting Officer in October 2009. Mr. Ragle was IsoRay’s Cost Accounting Manager from January 2007 until October 2009. Before joining IsoRay in January 2007 as Cost Accounting Manager, Mr. Ragle was employed by BNG America, LLC, a wholly-owned subsidiary of Energy Solutions, LLC (ES) from 2005 to 2006 as Project Accounting Manager for all projects located in the Western United States and from 2000 to 2004 as a Business Unit Controller by SCM Consultants, Inc, a wholly-owned subsidiary of Tetra Tech, Inc (TTEK). Mr. Ragle holds Bachelor of Arts degrees in Business Administration with an emphasis in accounting, and Hospitality Management from Washington State University. Mr. Ragle is a Certified Public Accountant in the State of Washington. Mr. Ragle filed for personal bankruptcy under Chapter 13 of the U.S. Bankruptcy Code on January 26, 2011. |
Fred Swindler |
Mr. Fredric Swindler is Vice President - Regulatory and Quality Assurance of IsoRay Inc. He joined IsoRay Medical in October 2006 and has over 40 years experience in manufacturing and regulatory compliance. Mr. Swindler also serves as Secretary for IsoRay, Inc., a position he has held since June 11, 2008. Mr. Swindler served as VP, Quality Assurance and Regulatory Affairs for Medisystems Corporation, a manufacturer and distributor of medical devices, from 1994 until joining the Company. During his tenure at Medisystems Corporation, Mr. Swindler developed a quality system to accommodate vertically integrated manufacturing, developed regulatory strategies, policies and procedures, and submitted nine pre-market notifications (510(k)) to the FDA. Prior to this, Mr. Swindler held various positions with Marquest Medical Products from 1989 to 1994, Sherwood Medical Products from 1978 to 1989, Oak Park Pharmaceuticals in 1978, and Mead Johnson & Company from 1969 to 1978. Mr. Swindler holds a Bachelor of Science degree in Biomedical Engineering from Rose-Hulman Institute of Technology and a Masters of Business Administration from the University of Evansville. |
William Cavanagh |
Mr. William Cavanagh, III is Vice President - Research and Development of IsoRay Inc. He joined IsoRay Medical in January 2010. Mr. Cavanagh has most recently been engaged in the research and development of dendritic cell therapies for cancer and infectious diseases. He served as Chief Scientific Officer for Sangretech Biomedical, LLC for the six years prior to joining IsoRay Medical. At Sangretech, he oversaw the design and implementation of a novel cancer therapy. Mr. Cavanagh began his career in cancer treatment technologies in the early 1990s, when he helped lead research and development of a therapy involving the insertion of radioactive sources directly into the prostate for the treatment of prostate cancer (prostate brachytherapy). He has designed several cancer treatment-related studies, is listed as an author on 34 peer-reviewed publications, and is the listed inventor on a U.S. patent application detailing a novel treatment for cancer. Mr. Cavanagh has also served as Director of the Haakon Ragde Foundation for Advanced Cancer Studies in Seattle, Washington, where he led the research foundation in the selection of viable research projects directed at treating advanced cancers. Mr. Cavanagh holds a B.S. in Biology from the University of Portland (Oregon) and completed two years of medical school before beginning his career in research management. |
Thomas LaVoy |
Mr. Thomas C. LaVoy is Independent Director of IsoRay Inc. Mr. LaVoy has served as Chief Financial Officer of SuperShuttle International, Inc., since July 1997 and as Secretary since March 1998. SuperShuttle is one of the providers of shuttle services in cities throughout the West and Southwest regions of the United States. He has also served as a director of Alanco Technologies, Inc. (OTCBB: ALAN) since 1998 and presently serves on its audit committee. From September 1987 to February 1997, Mr. LaVoy served as Chief Financial Officer of NASDAQ-listed Photocomm, Inc. Mr. LaVoy was a Certified Public Accountant with the firm of KPMG Peat Marwick from 1980 to 1983. Mr. LaVoy has a Bachelor of Science degree in Accounting from St. Cloud University, Minnesota, and is a Certified Public Accountant. Mr. LaVoy brings over 25 years of CFO experience for progressively growing companies in multiple industries to his service on the Company's Board. |
Albert Smith |
Mr. Albert Smith is Independent Director of IsoRay Inc. Mr. Smith was the co-founder of and served as Vice Chairman of CSI Leasing, Inc., a private computer leasing company from 1972 until March 2005. He founded Extreme Video Solutions, LLC a privately held video conferencing company with headquarters in Scottsdale, Arizona in December 2005. In January 2008, he formed Face to Face Live, Inc. (successor to Extreme Video Solutions) where he presently serves as CEO. Mr. Smith presently serves as Chairman of the Board for Doulos Ministries, Inc. Mr. Smith has experience in marketing and sales having managed a national sales force of over fifty people while at CSI Leasing, Inc. Mr. Smith holds a BS in Business Administration from Ferris State College. |
Basic Compensation
| Name | Fiscal Year Total |
|---|---|
Dwight Babcock |
318,290 |
Robert Kauffman |
-- |
Brien Ragle |
117,251 |
Fred Swindler |
168,757 |
William Cavanagh |
169,187 |
Thomas LaVoy |
-- |
Albert Smith |
-- |
As Of 29 Jun 2012
Options Compensation
| Name | Options | Value |
|---|---|---|
Dwight Babcock |
0 | 0 |
Robert Kauffman |
0 | 0 |
Brien Ragle |
0 | 0 |
Fred Swindler |
0 | 0 |
William Cavanagh |
0 | 0 |
Thomas LaVoy |
0 | 0 |
Albert Smith |
0 | 0 |
| Name | Shares Traded | Price |
|---|---|---|
LAVOY THOMAS C |
18,100 | $0.49 |
BABCOCK DWIGHT WILLIAM |
500 | $0.40 |
BABCOCK DWIGHT WILLIAM |
7,100 | $0.40 |
BABCOCK DWIGHT WILLIAM |
2,500 | $0.40 |
KAUFFMAN ROBERT R |
25,000 | $0.38 |
BABCOCK DWIGHT WILLIAM |
4,800 | $0.37 |
BABCOCK DWIGHT WILLIAM |
20,000 | $0.43 |
BABCOCK DWIGHT WILLIAM |
5,000 | $0.42 |
BABCOCK DWIGHT WILLIAM |
10,000 | $0.42 |
BABCOCK DWIGHT WILLIAM |
100 | $0.37 |
RAGLE BRIEN |
11,334 | $0.26 |
RAGLE BRIEN |
400 | $0.99 |
RAGLE BRIEN |
10,934 | $0.99 |
BABCOCK DWIGHT WILLIAM |
1,000 | $0.52 |
BABCOCK DWIGHT WILLIAM |
4,900 | $0.53 |
BABCOCK DWIGHT WILLIAM |
1,000 | $0.52 |
BABCOCK DWIGHT WILLIAM |
4,900 | $0.53 |
BABCOCK DWIGHT WILLIAM |
100 | $0.50 |
BABCOCK DWIGHT WILLIAM |
100 | $0.50 |
BABCOCK DWIGHT WILLIAM |
4,000 | $0.50 |
BABCOCK DWIGHT WILLIAM |
4,000 | $0.50 |
BABCOCK DWIGHT WILLIAM |
500 | $0.51 |
BABCOCK DWIGHT WILLIAM |
500 | $0.51 |
BABCOCK DWIGHT WILLIAM |
10,000 | $0.54 |
BABCOCK DWIGHT WILLIAM |
10,026 | $0.68 |
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
